Patent · US Active

Highly concentrated formulations of soluble Fc receptors

US12048728B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Inventors

Peter Sondermann · Stockdorf, DE
Thomas Pohl · Holzgerlingen, DE

Key dates

Filing date	Jan 25, 2022
Grant date	Jul 30, 2024
Priority date	—
Expiry date	Apr 7, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel formulations of soluble Fc receptors and especially to formulations containing high concentrations of soluble FcγRIIB receptor. The invention further relates to the use of such formulations as pharmaceutical compounds for the treatment of autoimmune diseases, infections and other conditions where the immune system is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.